Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 GBX | 0.00% | +6.06% | -20.00% |
May. 08 | Hellenic Dynamics and Ondine Biomedical raise funds | AN |
May. 03 | Ondine Biomedical shares rise on fundraise to advance Steriwave | AN |
Sales 2023 * | 1.18M 865K | Sales 2024 * | 2.6M 1.9M | Capitalization | 27.14M 19.84M |
---|---|---|---|---|---|
Net income 2023 * | -15M -10.97M | Net income 2024 * | -18M -13.16M | EV / Sales 2023 * | 22 x |
Net cash position 2023 * | 1.1M 804K | Net cash position 2024 * | 3.8M 2.78M | EV / Sales 2024 * | 8.98 x |
P/E ratio 2023 * |
-1.49
x | P/E ratio 2024 * |
-2.41
x | Employees | 18 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 22.43% |
Latest transcript on Ondine Biomedical Inc.
1 week | +6.06% | ||
Current month | +30.23% | ||
1 month | -6.67% | ||
3 months | -31.71% | ||
6 months | -34.58% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Bill Kanz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 21-12-06 |
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 7 | 0.00% | 91,231 |
24-05-09 | 7 | 0.00% | 698,607 |
24-05-08 | 7 | 0.00% | 4,781,295 |
24-05-07 | 7 | +6.06% | 1,509,456 |
24-05-03 | 6.6 | +28.78% | 1,172,667 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 19.86M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 67.92B | |
+2.39% | 50.96B | |
+9.36% | 44.7B | |
+2.70% | 40.66B | |
+24.51% | 27.6B | |
+3.43% | 26.63B | |
-0.32% | 24.98B |
- Stock Market
- Equities
- OBI Stock